Related Experiment Video

Updated: May 22, 2026

A Mimic of the Tumor Microenvironment: A Simple Method for Generating Enriched Cell Populations and Investigating Intercellular Communication
09:52

A Mimic of the Tumor Microenvironment: A Simple Method for Generating Enriched Cell Populations and Investigating Intercellular Communication

Published on: September 20, 2016

Higher expression of Caveolin-1 inhibits human small cell lung cancer (SCLC) apoptosis in vitro

Xiaohan Yang1, Hai Xiong, Zhu-zhu Guan

  • 1Department of Histology and Embryology, Dalian Medical University, Dalian, China.

Cancer Investigation
|May 2, 2012
PubMed

Insights

Higher Caveolin-1 expression inhibits apoptosis in small cell lung cancer (SCLC) cells treated with cisplatin or UV radiation. This suggests Caveolin-1 acts as an anti-apoptosis protein in SCLC, impacting cancer treatment strategies.

Area of Science:

  • Oncology
  • Molecular Biology
  • Cancer Research

Background:

  • Small cell lung cancer (SCLC) is an aggressive malignancy.
  • Apoptosis is a critical factor in SCLC treatment.
  • Caveolin-1 is implicated in various human cancers.

Purpose of the Study:

  • To investigate the role of Caveolin-1 in SCLC apoptosis.
  • To determine how Caveolin-1 influences SCLC cell response to apoptosis-inducing agents.

Main Methods:

  • In vitro study of SCLC cells.
  • Assessing apoptosis inhibition by Caveolin-1.
  • Measuring caspase-3 activity.
  • Analyzing Bcl-2 protein stability.

Main Results:

  • Elevated Caveolin-1 expression suppressed cisplatin-induced apoptosis in SCLC cells.
  • Increased Caveolin-1 inhibited Ultraviolet Radiation (UVR)-induced apoptosis.
  • Caveolin-1 overexpression reduced caspase-3 activity.
  • Higher Caveolin-1 levels correlated with increased Bcl-2 protein stability.

Conclusions:

  • Caveolin-1 functions as an anti-apoptosis protein in SCLC.
  • Caveolin-1 may influence SCLC treatment outcomes by modulating apoptosis pathways.
  • Understanding Caveolin-1's role offers potential therapeutic insights for SCLC.

Related Concept Videos

The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
Caspases01:24

Caspases

Caspase, a family of cysteine proteases, serve as effectors in apoptosis. The ced3 gene in C.elegans was first identified to be involved in apoptosis. This gene encodes the ced-3 caspase that is similar to the interleukin-1-beta converting enzyme or ICE in mammals. In addition to apoptosis, caspases also function in the inflammatory response. Inflammatory caspases are essential in activating pro-inflammatory cytokines that recruit immune cells and block the replication of pathogens inside cells.